Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age.
about
Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipientsInter-society consensus document on treatment and prevention of bronchiolitis in newborns and infantsChallenges and opportunities in developing respiratory syncytial virus therapeuticsClinical and radiological features of respiratory syncytial virus in solid organ transplant recipients: a single-center experience.Epidemiology and potential preventative measures for viral infections in children with malignancy and those undergoing hematopoietic cell transplantationRespiratory Tract Infections Due to Human Metapneumovirus in Immunocompromised ChildrenHuman rhinovirus C infections in pediatric hematology and oncology patients.Parainfluenza virus infections in children with hematologic malignanciesPreventing hospitalizations for respiratory syncytial virus infectionProspective detection of respiratory pathogens in symptomatic children with cancerAcute respiratory infections in children and adolescents with acute lymphoblastic leukemia.Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis.Clinical outcomes in outpatient respiratory syncytial virus infection in immunocompromised children.Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats.Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcomePredictors of severity and mortality in children hospitalized with respiratory syncytial virus infection in a tropical region.Managing fungal and viral infections in pediatric leukemia.Respiratory syncytial virus: current progress in vaccine development.Translational sciences approach to RSV vaccine development.Management of Acute Myeloid Leukemia in the Intensive Care Setting.Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases.Infectious complications in children with acute lymphoblastic leukemia treated in low-middle-income countries.Respiratory syncytial virus pathophysiology and affect of palivizumab in special populations: cystic fibrosis and immunosuppression.The clinical and phylogenetic investigation for a nosocomial outbreak of respiratory syncytial virus infection in an adult hemato-oncology unit.RSV infection without ribavirin treatment in pediatric hematopoietic stem cell transplantation.Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based cohort study.Case report of severe myocarditis in an immunocompromised child with Respiratory Syncytial Virus infection.The impact of RSV, adenovirus, influenza, and parainfluenza infection in pediatric patients receiving stem cell transplant, solid organ transplant, or cancer chemotherapy.Prévenir les hospitalisations pour l’infection par le virus respiratoire syncytial.Respiratory syncytial virus vaccine development
P2860
Q26829188-D9DDFE9A-7A3E-4059-B219-B580AA115A86Q27027386-9CCB43F7-A116-4830-A2B7-696D60710C96Q30300567-0E2E586D-5B08-4BBC-A45A-E109E5069B52Q30409593-37220EF7-DEB9-4C81-B0B6-07CDD34C040EQ33559473-78E4AFBE-9342-4216-9005-B08683D14119Q34556228-59A66D4A-5D3A-429B-B6AA-04F0C840825EQ34791363-DC77E7B3-24E3-4A4D-94CC-F7ADFAA1F088Q35384114-6F837996-D168-47E7-BDAB-7FB04EDD5AC6Q36082195-FBC885E6-0F9F-4A0B-A553-0FB3BDC28C81Q36498949-557EA287-F453-4821-96A3-268C747BACABQ36609554-96FC0082-0293-486D-99C5-A42D5511DB3BQ36652819-CCC29708-05DA-48A5-B391-2516D548C5FAQ36748198-8F0E000C-8FBB-40DD-88B4-3C35DC25CE28Q37320191-8A7E993A-2BEB-42DB-A6F5-4E581251E925Q37726073-C39E0E64-B766-413E-B83C-82E4C9DBFBB5Q37727985-E128C457-E0C0-4B2F-BE82-31CC5F987B75Q37810281-8DF20F4F-01AC-4EE1-8C6B-94C8AD507958Q38079432-F940299E-3588-4DC8-A68A-BCABD41E5E32Q38140040-C1CF0D76-CE00-4A37-A679-B12FCD9DFC5CQ38206394-32906D52-033F-4E97-BA4F-944EA349F838Q38373552-8460263E-EAB3-42FB-A163-CF7B75946A11Q38388198-38F9B8DF-B764-4C8F-8698-2E8B21891A92Q38945689-D9CD0981-867A-4C46-AF4F-D4EEC1F32353Q40316430-F7CE3744-3BF9-47F5-A4FA-B5589DBE34BAQ40673394-4B56348E-3EAA-4BCE-AFAA-0D7514A47B50Q45354070-96F40A50-CA15-4706-BA6F-6EEEECA2D099Q49509385-8AB41C23-D4A0-4B00-9AD5-AB258DBBAA30Q53130111-ABB9BFE3-2E3B-4EAB-A1A6-49152583B74BQ53932344-B9026E6E-0A10-4003-AE97-B59DDBCB0654Q56893551-0DEA9F24-F0B0-4436-9F3B-340A42FD6AEA
P2860
Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Risk factors for severe respir ...... of lymphopenia and young age.
@en
Risk factors for severe respir ...... of lymphopenia and young age.
@nl
type
label
Risk factors for severe respir ...... of lymphopenia and young age.
@en
Risk factors for severe respir ...... of lymphopenia and young age.
@nl
prefLabel
Risk factors for severe respir ...... of lymphopenia and young age.
@en
Risk factors for severe respir ...... of lymphopenia and young age.
@nl
P2093
P356
P1433
P1476
Risk factors for severe respir ...... of lymphopenia and young age.
@en
P2093
Aditya H Gaur
Chadi M El Saleeby
Grant W Somes
John P DeVincenzo
P304
P356
10.1542/PEDS.2007-1102
P407
P577
2008-02-01T00:00:00Z